New TRUST Trial Data Confirm Clinical Benefits Of BIOTRONIK Home Monitoring(R)

BIOTRONIK SE & Co. KG, the pioneer of wireless remote monitoring technologies and leading manufacturer of implantable cardiac devices, announced that new data from the TRUST (Lumos-T Safely Reduces Routine Office Device Follow Up) trial1 presented at the European Society of Cardiology Congress 2009 demonstrate the benefits of BIOTRONIK Home Monitoring in the early detection of patient clinical events as well as the safe reduction of in-office follow-up visits.